Home

Centre for Cancer Biomarkers CCBIO

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

Open Access - Plan S
Open Access logo

Norwegian research communities join forces to change new Open Access plan

The Norwegian Research Council and other European research councils are about to make a radical alteration of the scientific publishing model by forcing Open Access for all scientific work. The scheme is called Plan S. 27 Norwegian research leaders, including CCBIO Director Lars A. Akslen, suggest...

next generation immunohistochemistry
Hyperion imaging photo
Feb 06

Opening symposium for the Hyperion Imaging System

The Centre for Cancer Biomarkers CCBIO and the Bergen Flow Cytometry Core Facility present the brand new Hyperion Imaging System, now available to the Medical Faculty research groups! The opening symposium will introduce you to the research possibilities offered by the Hyperion Imaging System, give...

Sabbatical report
Front of building

Reflections from sabbatical at Moores Cancer Center, University of California, San Diego

CCBIO Associate Investigator Dana Costea is currently on a sabbatical at Moores Cancer Center at the University of California, San Diego, and reports of a great learning experience on cell signaling and molecular techniques, collaboration strategies and leadership styles, the center’s exemplary way...

Financial support
X-ray, tomography and MRI scans of the Human head

New support from Helse Vest

CCBIO Associate Investigator Daniela Elena Costea received support for 3 years (4.5 milion kr) from Western Norway Regional Health Authority (Helse Vest) for the project "Defining molecular subtypes of head and neck cancer by integrative mutational, stromal and inflammatory landscape analysis...

regognition
Portrait photo.

Best presentation at the NSGO Annual Meeting

CCBIO PhD Candidate Hilde Engerud in the Gynecologic Cancer Research Group was awarded with Best Presentation at the annual meeting of the Norwegian Society for Gynecology and Obstetrics this fall, October 25 and 26 2018.

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.